Fenwick Two-Part Series: Staying Ahead of Regulatory Pressure in Life Sciences and Tech

Join us for two in-person CLE sessions at Fenwick’s Seattle office. These sessions will explore key regulatory issues impacting business growth, legal strategy, and investment decisions.

Session 1: Scaling Smarter: Navigating Life Sciences Regulation & Antitrust Risk from Seed to Exit (9:00–10:30 AM, breakfast provided)

As digital health and life sciences companies scale, regulatory and antitrust complexity can quickly outpace internal resources. This session will provide practical, stage-specific guidance for mitigating risk while supporting growth. 

Topics will include:

• Key compliance issues across federal and state regulations, commercialization, and privacy
• Common antitrust pitfalls in communications, hiring, and strategic partnerships
• How to prepare for increased scrutiny from Series A through IPO or acquisition

Session 2: Staying Ahead of Scrutiny: Trade, Security & Contracting Strategies for Tech Companies (11:00 AM–12:30 PM, lunch provided)

As trade controls tighten and national security enforcement ramps up, tech companies face growing risks that can derail deals or stall growth. This session offers tactical, real-world guidance to stay ahead of a shifting federal and global environment.

Topics will include:

• Export control trends, strategic product classification, and customer and partner diligence
• Managing CFIUS and FOCI exposure in financings, strategic transactions, and joint ventures
• Government procurement trends and restrictions

Register for this event here.